TRIM71 and ovarian carcinoma: These correlations also suggest that TRIM71 might regulate ovarian cancer cell proliferation (Fig. 4c and S1a–d), survival (Fig. 4d and S1e–g), metastasis (Fig. 4e and S1h), lipid metabolism (Fig. 4f and S1i–o), redox homeostasis (Fig. 4g and S1t–y), glycolysis (Fig. 4h), proteasome pathway (Fig. 4i and S1p–s), and chemoresistance (Fig. 4j) by antagonizing mtp53s’ GOFs.